|
|||||
|
|
FGFR2-Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape |
|
| Authors: | Samuel J Klempner Russell Madison Vivek Pujara Jeffrey S Ross Vincent A Miller Siraj M Ali Alexa B Schrock Seung Tae Kim Steven B Maron Farshid Dayyani Daniel VT Catenacci Jeeyun Lee Joseph Chao |
| Affiliation: | 1. The Angeles Clinic and Research Institute, Los Angeles, California, USA;2. Foundation Medicine, Inc., Cambridge, Massachusetts, USA
Contributed equally.;3. Foundation Medicine, Inc., Cambridge, Massachusetts, USA Upstate Medical University, Syracuse, New York, USA;4. Foundation Medicine, Inc., Cambridge, Massachusetts, USA;5. Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea;6. Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA;7. Division of Hematology-Oncology, Department of Medicine, University of California Irvine, Orange, California, USA;8. Department of Medicine, Division of Hematology-Oncology, University of Chicago School of Medicine, Chicago, Illinois, USA;9. Department of Developmental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California, USA |
| Abstract: | |
| Keywords: | Fibroblast growth factor receptor 2 Gastric cancer Gastroesophageal junction adenocarcinoma Heterogeneity Receptor tyrosine kinase |
